Literature DB >> 2578284

Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.

P A Edwards.   

Abstract

Most monoclonal antibodies that have been raised to human epithelial tumours bind to only some of the cells in a tumour, showing that tumour cells are very heterogeneous in their expression of antigens. Normal epithelia show the same heterogeneity of antigen expression, as also do cell lines and clones of epithelial cells in culture. It is not related to the mitotic cell cycle. Many, probably most of the antigenic determinants to which the antibodies bind are carbohydrate structures. It is not clear whether variations in antigen expression reflect variations in the differentiated state of the cells or merely variations in the carbohydrate structures on otherwise identical cells, nor is ir clear whether antibodies could be made that bind to all tumour cells by avoiding antibodies to carbohydrate structures. The normal and apparently reversible nature of this heterogeneity of antigen expression conflicts with conventional views that heterogeneity among cells of a tumour is due to permanent genetic change. The heterogeneity within normal clones suggests that cloning is not an adequate way to study heterogeneity in tumour cells. The implications of heterogeneous expression of antigens within tumours for therapeutic and diagnostic application of antibodies are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578284      PMCID: PMC1977033          DOI: 10.1038/bjc.1985.24

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  69 in total

1.  Implications of immunological heterogeneity of tumours.

Authors:  R S Kerbel
Journal:  Nature       Date:  1979-08-02       Impact factor: 49.962

2.  Modulation of phenotype in cultures of human milk epithelial cells and its relation to the expression of a membrane antigen.

Authors:  S E Chang; J Taylor-Papadimitriou
Journal:  Cell Differ       Date:  1983-03

3.  Mouse monoclonal antibody F-3 recognizes the difucosyl type-2 blood group structure.

Authors:  K O Lloyd; G Larson; N Strömberg; J Thurin; K A Karlsson
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

Review 4.  Monoclonal antibodies and human tumor pathology.

Authors:  A M Neville; C S Foster; V Moshakis; M Gore
Journal:  Hum Pathol       Date:  1982-12       Impact factor: 3.466

5.  Many monoclonal antibodies with an apparent specificity for certain lung cancers are directed against a sugar sequence found in lacto-N-fucopentaose III.

Authors:  L C Huang; M Brockhaus; J L Magnani; F Cuttitta; S Rosen; J D Minna; V Ginsburg
Journal:  Arch Biochem Biophys       Date:  1983-01       Impact factor: 4.013

6.  Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.

Authors:  L D Cahan; R F Irie; R Singh; A Cassidenti; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Immunochemical analysis of the determinant recognized by a monoclonal antibody (MBr1) which specifically binds to human mammary epithelial cells.

Authors:  S Canevari; G Fossati; A Balsari; S Sonnino; M I Colnaghi
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

8.  Generation of monoclonal antibodies reacting with normal and cancer cells of human breast.

Authors:  S Mènard; E Tagliabue; S Canevari; G Fossati; M I Colnaghi
Journal:  Cancer Res       Date:  1983-03       Impact factor: 12.701

9.  The membrane antigens of human colorectal cancer cells: demonstration with monoclonal antibodies of heterogeneity within and between tumours and of anomalous expression of HLA-DR.

Authors:  A S Daar; J W Fabre
Journal:  Eur J Cancer Clin Oncol       Date:  1983-02

10.  Do metastases arise from pre-existing subpopulations of cancer cells?

Authors:  L Weiss; J C Holmes; P M Ward
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

View more
  37 in total

1.  Extensive intra-tumor heterogeneity in primary human glial tumors as a result of locus non-specific genomic alterations.

Authors:  A Misra; P Chattopadhyay; A K Dinda; C Sarkar; A K Mahapatra; S E Hasnain; S Sinha
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Epithelial glycoprotein is a member of a family of epithelial cell surface antigens homologous to nidogen, a matrix adhesion protein.

Authors:  B Simon; D K Podolsky; G Moldenhauer; K J Isselbacher; S Gattoni-Celli; S J Brand
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Cell surface antigens of human trophoblast: definition of an apparently unique system with a monoclonal antibody.

Authors:  U W Mueller; C S Hawes; W R Jones
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

4.  Near-infrared fluorescence imaging of cancer mediated by tumor hypoxia and HIF1α/OATPs signaling axis.

Authors:  Jason Boyang Wu; Chen Shao; Xiangyan Li; Changhong Shi; Qinlong Li; Peizhen Hu; Yi-Ting Chen; Xiaoliang Dou; Divya Sahu; Wei Li; Hiroshi Harada; Yi Zhang; Ruoxiang Wang; Haiyen E Zhau; Leland W K Chung
Journal:  Biomaterials       Date:  2014-06-21       Impact factor: 12.479

Review 5.  Review: biologic heterogeneity of cancer metastases.

Authors:  I J Fidler
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

6.  Heterogeneous expression of a murine B16 melanoma-associated antigen correlates with cell cycle.

Authors:  S P Leong; P D Noguchi; R E Cunningham; T Takami; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Primary polyoma virus-induced murine thymic epithelial tumors. A tumor model of thymus physiology.

Authors:  G P Hoot; J R Kettman
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

8.  A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the pancreas.

Authors:  K Bosslet; H F Kern; E J Kanzy; A Steinstraesser; A Schwarz; G Lüben; H U Schorlemmer; H H Sedlacek
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 9.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Identification of extra-villous trophoblast cells in human decidua using an apparently unique murine monoclonal antibody to trophoblast.

Authors:  U W Mueller; C S Hawes; W R Jones
Journal:  Histochem J       Date:  1987-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.